Empowered Community Partnership Center - The Mason Empowered Communities Partnership Center aims to address the opioid epidemic by taking a comprehensive, multi-faceted approach to education, prevention, treatment, and collective impact. The project focuses on individuals affected by the opioid epidemic, with a particular emphasis on those who are unsheltered, involved in the criminal justice system, and youth and adolescents. The center will provide comprehensive support services, including access to evidence-based best practice strategies, co-located services, low barriered and rapid access to medication for opioid use disorder (MOUD), as well as behavioral therapies, peer support networks, and peer recovery specialists. Through this center we will expand substance use disorder (SUD) treatment and related recovery services for 2,450 individuals with a substance/opioid use disorder and/or co-occurring substance use and mental health disorder. Through this public health collaborative effort, we will increase the collective impact across communities and leverage partnerships to establish effective high touch interventions for high risk individuals. The center's goals include: (1) Promoting the use of evidence-based best practice strategies across sectors and agencies by providing comprehensive training, education, and awareness programs; (2) Increase access and engagement in evidence-based treatment services by establishing co-located services for adults and youth in crisis from opioid use disorder (OUD) where there are identified gaps in service provision; and (3) Establishing cross-sector partnerships to develop and implement effective strategies that address the root causes of the opioid epidemic, including social influences of health, poverty, and trauma, through targeted interventions and policies. The project's objectives are measurable, and it intends to train and disseminate evidence-based best practices to 1000 individuals, reach 100,000 individuals through education and awareness campaigns, provide care to at least 500 individuals, and offer evidence-based treatment services to 200 individuals by July 1, 2024.